Key result
Radiotherapy in CIED patients shows ~0.4% device failure, though asymptomatic parameter changes occur frequently.
Why the study?
As an aging population leads to more patients with cardiac implantable electronic devices undergoing radiotherapy, ensuring device safety and understanding the effects of irradiation on device function and lead variables are crucial.
Does radiotherapy affect device function and lead parameters in patients with a cardiac implantable electronic device (CIED)?
Cohort (n=279)
No
Does radiotherapy affect device function and lead parameters in patients with a cardiac implantable electronic device (CIED)?
Radiotherapy poses a very small safety and functional risk (0.4% device failure rate) to cardiac implantable electronic devices, and although subclinical lead impedance variations are common, they are not dose-dependent or increased by repeated radiotherapy courses.
Answers are grounded in this paper and cite their sources.
Impedance changes during radiotherapy were mostly asymptomatic with low error rates; leaves open whether adjusted CIED monitoring protocols are warranted.
Background and purpose As the population ages, an increasing number of patients are undergoing radiotherapy with an implanted cardiac device. Therefore, ensuring the safety of these devices during radiotherapy is crucial. This study aims to analyse the effect of radiotherapy on such devices, with a particular focus on changes in lead variables. Methods This retrospective study examined all patients with a cardiac implantable electronic device (CIED) who underwent radiotherapy at a single institution between 2012 and 2022. Device function and associated changes in lead parameters were analysed before and after radiotherapy. Results The study cohort included 279 patients who underwent 310 courses of radiotherapy. During the 11-year study period, one device failure requiring replacement due to a software error was recorded. This occurred following irradiation with 15 MV photons. Changes in individual lead parameters were more common, occurring in almost half of all radiotherapy courses. Lead impedances were particularly sensitive to changes, with high-voltage impedances being affected more frequently (61% of impedances) than other impedances. Sensing, pacing thresholds, and battery voltage were less frequently affected, with changes occurring in fewer than 10% of the analysed leads or batteries. None of the observed changes manifested as clinical symptoms. There was no statistically significant association between radiation parameters and the observed changes in lead values with only a few courses using neutron-generating photon energies. Furthermore, no dose-effect relationship for device doses could be established. Receiving multiple courses of radiotherapy in one year or over several years did not increase the risk to the device or cause greater variation in lead variables. Conclusion Only one safety event occurred during the observation period, resulting in an error rate of 0.4% across 11 years and 279 patients. Changes in individual lead parameters were more frequent. However, no clear association could be established between the observed changes and radiation parameters. In particular, changes in lead variables were not explained by the dose to the device or repeated courses of radiotherapy. Therefore, the risk to the safety and function of cardiac devices from radiotherapy appears to be small.
No takes yet. Share an insight, caveat, or question.
Christiansen et al. (2026) conducted a cohort in Patients with a cardiac implantable electronic device (CIED) undergoing radiotherapy (n=279). Radiotherapy vs. Pre-radiotherapy baseline device and lead parameters was evaluated on Device failure/safety events and changes in lead parameters. Radiotherapy in patients with cardiac implantable electronic devices resulted in a 0.4% device failure rate (1/279 patients) over 11 years, with asymptomatic lead parameter changes in nearly half.
Synapse has enriched 10 related papers. Consider them for comparative context: